These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7044791)

  • 1. Orgotein, a new drug for the treatment of Peyronie's disease.
    Bartsch G; Menander-Huber KB; Huber W; Marberger H
    Eur J Rheumatol Inflamm; 1981; 4(2):250-9. PubMed ID: 7044791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orgotein in the treatment of plastic induration of the penis (Peyronie's disease).
    Primus G
    Int Urol Nephrol; 1993; 25(2):169-72. PubMed ID: 8365848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peyronie's disease: experience of local treatment with Orgotein.
    Gustafson H; Johansson B; Edsmyr F
    Eur Urol; 1981; 7(6):346-8. PubMed ID: 7286003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Orgotein iontophoresis in the therapy of induratio penis plastica].
    Schieroni MP; Revello MP; Colombo M; Randone DF; Rolle L
    Minerva Med; 1985 May; 76(22-23):1085-8. PubMed ID: 3892367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The conservative treatment of Peyronie's disease with orgotein].
    Ianev V; Tsvetkov D
    Khirurgiia (Sofiia); 1989; 42(6):57-9. PubMed ID: 2634802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic corticosteroid treatment in Peyronie's disease.
    Uzun H
    Med Hypotheses; 2013 Dec; 81(6):1029-30. PubMed ID: 24119766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
    Riedl CR; Sternig P; Gallé G; Langmann F; Vcelar B; Vorauer K; Wagner A; Katinger H; Pflüger H
    Eur Urol; 2005 Oct; 48(4):656-61. PubMed ID: 15982798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orgotein: a new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract.
    Marberger H; Huber W; Bartsch G; Schulte T; Swoboda P
    Int Urol Nephrol; 1974; 6(2):61-74. PubMed ID: 4615073
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity reaction after orgotein (superoxide dismutase) administration.
    Corominas M; Bas J; Romeu A; Valls A; Massip E; González L; Mestre M; Buendía E
    Allergol Immunopathol (Madr); 1990; 18(5):297-9. PubMed ID: 2151501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induratio penis plastica. Therapy with orgotein].
    Bickeböller R; Balducci M; Jonas D
    Fortschr Med; 1988 Sep; 106(27):558-60. PubMed ID: 3181851
    [No Abstract]   [Full Text] [Related]  

  • 13. Orgotein: a new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease.
    Lund-Olesen K; Menander KB
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):706-17. PubMed ID: 4210460
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [La Peyronie's disease. Our experience].
    Revelli G; Marino B; Piccoli F; Vitale L; Kiss A; Rossi R; Lanfranchi M; Drago GW
    Minerva Chir; 1990 Jan; 45(1-2):47-50. PubMed ID: 2186297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Orgotein and La Peyronie's disease].
    Boccafoschi C; Montefiore F
    Minerva Urol Nefrol; 1987; 39(2):125-8. PubMed ID: 3629408
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis).
    Ludwig G
    Urol Int; 1991; 47(4):236-9. PubMed ID: 1781108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-articular orgotein therapy in osteoarthritis of the knee. A double-blind, placebo-controlled trial.
    Lund-Olesen K; Menander-Huber KB
    Arzneimittelforschung; 1983; 33(8):1199-203. PubMed ID: 6357204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.
    Montorsi F; Salonia A; Guazzoni G; Barbieri L; Colombo R; Brausi M; Scattoni V; Rigatti P; Pizzini G
    J Androl; 2000; 21(1):85-90. PubMed ID: 10670523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.